SecurityScorecard, a security rating and continuous risk monitoring platform, released its 2016 Healthcare Industry Cybersecurity Report in October. The report is a comprehensive analysis exposing alarming cybersecurity vulnerabilities across 700 healthcare organizations including medical treatment facilities, health insurance agencies and healthcare manufacturing companies. Security breaches in this industry pose devastating consequences, according to the company, because they can render an entire system or network inoperable, creating a life or death situation that needs immediate attention.

White coat hypertension, where patients have high blood pressure readings in a medical setting but normal blood pressure outside the doctor’s office, is most likely an innocuous condition that is not a predictor of heart disease or stroke — except in a small group of older patients. This conclusion was drawn from a study published recently in the Journal of the American College of Cardiology.

Optical coherence tomography (OCT) provides safe and improved guidance for patients undergoing percutaneous coronary intervention to treat coronary artery disease, according to results from the ILLUMIEN III: OPTIMIZE PCI trial. The trial sought to determine whether a novel OCT-based stent sizing strategy would result in a comparable or superior minimal stent area (MSA) as achieved with former stent implant imaging techniques.

Mitralign will present data on its Trialign Tricuspid Repair system at the 2016 Transcatheter Cardiovascular Therapeutics (TCT) conference, which will be held in Washington, D.C. Oct. 29-Nov. 2. The company will be presenting 30-day data from SCOUT I, a U.S. multi-center, early feasibility study (EFS).

October 27, 2016 — Abiomed Inc. said the U.S. Food and Drug Administration (FDA)gave approval for a prospective ...

For the first time, fetal medicine experts have performed prenatal heart surgery to remove a life-threatening tumor, called intrapericardial teratoma. The patient, who underwent the operation at 24 weeks of gestation while in his mother’s womb, is now a healthy three-year-old preschooler.

Svelte Medical Systems Inc. announced this week it received CE Mark certification of the Direct Sirolimus-Eluting Coronary Stent Rapid-Exchange (RX) System for the treatment of coronary artery disease. The first patient to receive Direct RX was treated by Auke Weevers, M.D., a practicing interventional cardiologist at Albert Schweitzer Ziekenhuis in Dordrecht, The Netherlands.

October 28, 2016 – Tryton Medical Inc., a primary developer of stents to treat coronary bifurcation lesions, and ...